Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
---|
02/13/2003 | US20030032093 Production of secreted polypeptides |
02/13/2003 | US20030032092 DNA molecules, preparation and use in gene therapy |
02/13/2003 | US20030032086 Mixture for use as tool in propagation of nucleotide sequences |
02/13/2003 | US20030032085 An expression cassette comprising a transcriptional initiation region, consisting of a 5' non-coding region regulating the transcription of patched protein, a marker gene, and a transcriptional termination region |
02/13/2003 | US20030032080 Novel potentially fluorogenic compounds and plating media containing same |
02/13/2003 | US20030032079 Apparatus and method for testing effects of materials and surface coating on the formation of biofilms |
02/13/2003 | US20030032060 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
02/13/2003 | US20030032036 Expression vector for use in the analysis and classification of antibiotic biosynthetic pathways |
02/13/2003 | US20030032032 Diagnosing viral brain disorders; obtain sample nucleic acids, incubate with marker probe, denature, hybridize, detect signal from probe, presence of signal indicates viral infection |
02/13/2003 | US20030032018 Nucleotide sequences coding preferential plypeptide for use in the diagnosis and treatment of hypertension, hypotension, heart disease, asthma, and the like. |
02/13/2003 | US20030031999 Determining the translational efficiency of an individual codon in a cell; obtain cell, transform with expression vector, express vector, monitor gene expression and translation |
02/13/2003 | US20030031741 A metabolite produced by antibiotic-producing Streptomyces sp. strain NRRL No. B-30145 exhibiting fungacidal activity on Alternaria solani, Botrytis cinerea, Rhizoctonia sp., Sclerotinia sp., and Phytophthora sp. |
02/13/2003 | US20030031684 Growing a culture of a deep rough mutant bacterial strain in a medium, maintaining in stationary phase for > 5hr, harvesting the cells and extracting lipopolysaccharide |
02/13/2003 | US20030031683 Selecting for a strain of bacteria having an RpoS+ phenotype, inactivating mutations which render the strain attenutated, and a recombinant gene encoding the product |
02/13/2003 | US20030031682 Pathogens useful as vaccines for therapy and/ or prophylaxis |
02/13/2003 | US20030031679 Immunomodulatory peptides derived from heat shock proteins and uses thereof |
02/13/2003 | US20030031675 For the immunomodulation of a human or animal; decreasing T-cell proliferation |
02/13/2003 | US20030031663 Immunogenic polypeptides for inducing anti-self IgE responses |
02/13/2003 | US20030031659 For the treatment or prevention of a gastrointestinal infection caused by a pathogenic bacteria; for reducing insect and parasite populations in animal manure |
02/13/2003 | US20030031628 Imaging infection using fluorescent protein as a marker |
02/13/2003 | US20030029086 Floral packaging material having great masters prints thereon |
02/13/2003 | CA2456229A1 Epoxide hydrolases, nucleic acids encoding them and methods for making and using them |
02/13/2003 | CA2456007A1 Reduction in the virulence of mycobacterium tuberculosis and protection against tuberculosis by means of phop gene inactivation |
02/13/2003 | CA2455918A1 Hagfish cathelin-associated antimicrobial peptides and genes |
02/13/2003 | CA2455686A1 Methods for generating antibiotic resistant microbes and novel antibiotics |
02/13/2003 | CA2455237A1 Compositions and methods for generating chimeric heteromultimers |
02/13/2003 | CA2455194A1 Vascular endothelial growth factor isoform having anti-angiogenic activity |
02/13/2003 | CA2454696A1 Novel genetic products of ashbya gossypii, associated with the mechanisms of signal transduction and especially with the improvement of vitamin b2 production |
02/13/2003 | CA2454238A1 Method of detecting protease activity in a cell |
02/13/2003 | CA2453372A1 Methylation resistant vectors |
02/13/2003 | CA2451142A1 Carotenoid ketolase gene |
02/12/2003 | EP1283268A2 Recombinant vascular endothelial cell growth factor D (VEGF-D) |
02/12/2003 | EP1283267A1 Vector for analysing replication mechanism of rna virus and use thereof |
02/12/2003 | EP1283265A1 Process for producing protein with reduction of acidic sugar chain and glycoprotein produced thereby |
02/12/2003 | EP1283264A2 Interleukin-3 (IL-3) mutant polypeptides |
02/12/2003 | EP1283261A1 Method of screening drug acting on cell wall |
02/12/2003 | EP1283260A1 Novel insulin/igf/relaxin family polypeptides and dnas thereof |
02/12/2003 | EP1283259A1 Chondroitin polymerase and DNA encoding the same |
02/12/2003 | EP1283256A1 Method of culturing microorganism |
02/12/2003 | EP1283255A1 Myocardial cell proliferation-associated genes |
02/12/2003 | EP1282717A1 Nucleotide sequences coding for signal transduction components involved in plant pathogen defence |
02/12/2003 | EP1282716A1 Method for producing recombinant proteins by gram-negative bacteria |
02/12/2003 | EP1282715A2 Method for microbial production of difructose anhydride iii, micro-organism used therefor and enzyme with inulase ii activity and dna sequences coding therefor |
02/12/2003 | EP1282714A2 Modified inosine 5'-monophosphate dehydrogenase polypeptides and uses thereof |
02/12/2003 | EP1282713A2 Moss genes from physcomitrella patens encoding proteins involved in the synthesis of polyunsaturated fatty acids and lipids |
02/12/2003 | EP1282706A2 Natrium-calcium exchanger protein |
02/12/2003 | EP1282705A2 Endothelial differentiation gene 6-like g protein coupled receptor |
02/12/2003 | EP1282703A2 Rabies virus-specific neutralizing human monoclonal antibodies and nucleic acids and related methods |
02/12/2003 | EP1282701A2 Novel neuronally expressed protein and use thereof |
02/12/2003 | EP1282700A1 Neuronal serine-threonine protein kinase |
02/12/2003 | EP1282696A1 Ifi206, a novel interferon-induced polypeptide, and nucleic acids encoding the same |
02/12/2003 | EP1282688A1 Ammonia-oxidizing bacteria |
02/12/2003 | EP1282687A1 Microorganisms for treatment or prevention of obesity and diabetes mellitus, and pharmaceutical composition containing the same |
02/12/2003 | EP1282686A1 A recombinant yeast for lignocellulose raw materials |
02/12/2003 | EP1282684A2 Chondroitin synthase gene and methods of making and using same |
02/12/2003 | EP1282645A2 G protein-coupled receptors |
02/12/2003 | EP1282641A1 Human cervical cancer suppressor protein, polynucleotide encoding the protein, cell transformed with the polynucleotide and method for suppressing proliferation of cancer cell using the expression vector |
02/12/2003 | EP1282637A2 Purification of protein inclusion bodies by crossflow microfiltration |
02/12/2003 | EP1282636A2 Trp8, a transient receptor potential channel expressed in taste receptor cells |
02/12/2003 | EP1282626A2 Polyketide derivatives |
02/12/2003 | EP1282434A1 Method for cell adhesion and wound healing |
02/12/2003 | EP1282415A2 Compounds and methods for regulating bacterial growth and pathogenesis |
02/12/2003 | EP0865447B1 Cyclic dodecapeptide and process for the preparation thereof |
02/12/2003 | CN1396952A Bacteriolytic complex, method for producing said complex and strain for carrying out said method |
02/12/2003 | CN1396266A Process for testing parastic candida, tropical candida, etc |
02/12/2003 | CN1396257A SOD Qi orange and its production method |
02/12/2003 | CN1396256A Hair growth promoter and its preparing process and application |
02/12/2003 | CN1101469C Genes encoding enzymers of BalI restruction-modification system |
02/12/2003 | CN1101403C Preparation of granulocyte colony stimulation factor |
02/12/2003 | CN1101396C Isolation of claulanic acid from fermentation broth by ultrafiltration |
02/12/2003 | CN1101364C Production and application method of microbial fertilizer |
02/11/2003 | US6518403 Antibodies that bind an adipocyte-specific protein homolog |
02/11/2003 | US6518401 Polypeptide for use in the treatment and prevention of tumors and infections |
02/11/2003 | US6518400 Polypeptide that affects the organization of chromosomes within the nucleus; heterochromatin |
02/11/2003 | US6518316 Cytokine production and tyrosine kinase inhibitors |
02/11/2003 | US6518236 FGF homologs |
02/11/2003 | US6518066 Acylated Homoserine Lactone (AHL) compounds and AHL receptors derived from bacterial quorum sensing systems; inducible or repressible promotors regulate gene expression in plants and plant cells |
02/11/2003 | US6518063 Osf2/Cbfa1 nucleic acids and methods of use therefor |
02/11/2003 | US6518061 Interleukin-13 (IL-13); Delivery of a modified Pseudomonas exotoxin (effector molecule), attached to an interleukin, to tumor cells bearing interleukin receptors; antitumor agent |
02/11/2003 | US6518054 Genes encoding variants of metallo-endopeptidases that have been engineered to be resistant to prolonged boiling while having maintained their enzymatic performance at much lower temperatures. thermal stability of the metallo-endopeptidases |
02/11/2003 | US6518052 Human homologue of yeast helicase and uses thereof |
02/11/2003 | US6518046 DNA (RNA) encoding such chemolcine polypeptides. Moreover, a procedure for producing such polypeptides by recombinant techniques is disclosed. Also disclosed are methods for utilizing such Ck beta -9 polypeptides for the treatment of |
02/11/2003 | US6518043 Proteins suppressing proliferation of lympho-hematopoietic cells |
02/11/2003 | US6518042 A filamentous fungal cell, wherein a gene involved in the mismatch repair system has been inactivated and in which the gene involved in the mismatch repair system comprises a DNA sequence encoding the polypeptide sequence shown in positions |
02/11/2003 | US6518039 Such as 7-ADCA (3-methyl-4-carboxy-7-amino-3-cephem), via production of the 7-acylated counterparts |
02/11/2003 | US6518037 Two-component system that controls bacterial membrane synthesis |
02/11/2003 | US6518035 methods of screening for a molecule that inhibits the expression or activity of a protein encoded by a target gene which affects the fitness of a cell. The methods are based on a co-culture assay, and entail culturing together two cell |
02/11/2003 | US6518019 Enzymatic polypeptide for use as tools in the generation and amplification of preferential nucleotide sequences |
02/11/2003 | US6517829 Cells having expressed and immobilised at their outer surface active heavy chain antibodies from an animal in the family Camelidae |
02/11/2003 | CA2170509C Dna encoding prostaglandin receptor ep2 |
02/11/2003 | CA2123300C Method for preserving food products and products made thereby |
02/11/2003 | CA2111081C Use of metallic peroxides in bioremediation |
02/11/2003 | CA2068871C Non-glycosylated fgf-4 and compositions containing the same |
02/11/2003 | CA2005704C Pneumolysin mutants and pneumococcal vaccines made therefrom |
02/11/2003 | CA1341419C Process for the introduction of expressible genes into plant cell genomes and agrobacterium strains carrying hybrid ti plasmid vectors useful for this process |
02/10/2003 | WO2002014509A1 Glycerylaldehyde-3-phosphate dehydrogenase promoter inducing cell death |
02/10/2003 | CA2418777A1 Glycerylaldehyde-3-phosphate dehydrogenase promoter which induces apoptosis |
02/06/2003 | WO2003010333A2 Methods for gene disruption and uses thereof |
02/06/2003 | WO2003010324A2 Process for the preparation of simvastatin |
02/06/2003 | WO2003010315A1 Abca7 splicing variant |